It is one of the most-studied research peptides in current pre-clinical literature on cytoprotective signalling and tissue-repair models
This is
If administered by injection, local reactions such as redness, swelling, itching, or pain can occur, and improper technique can increase infection risk
Similarly, in the Phase I trial, two participants in the 5 10 6 cells/injection group experienced grade 1 adverse events (gum swelling and diarrhea) that may have been related to the injection
However, honest evaluation requires acknowledging the limitations and unknowns: Bioavailability Uncertainty: The percentage of orally administered BPC-157 that reaches systemic circulation in humans is not definitively established through published pharmacokinetic studies
Trial REDEFINE 2 Phase 3 Duration 68 weeks Population (N) 1,206 adults with T2D + obesity/overweight Key Result 13.7% mean weight change vs 3.4% placebo (treatment-policy)